Publikation

Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study.

Wissenschaftlicher Artikel/Review - 28.08.2014

Bereiche
PubMed
DOI
Kontakt

Zitation
De Marchis G, Weck A, Audebert H, Benik S, Foerch C, Buhl D, Schuetz P, Jung S, Seiler M, Morgenthaler N, Mattle H, Müller-Stich B, Christ-Crain M, Arnold M, Katan M. Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study. Stroke 2014; 45:2918-23.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Stroke 2014; 45
Veröffentlichungsdatum
28.08.2014
eISSN (Online)
1524-4628
Seiten
2918-23
Kurzbeschreibung/Zielsetzung

Copeptin has been associated with recurrent cerebrovascular events after transient ischemic attack (TIA). In an independent cohort, we evaluated copeptin for the prediction of recurrent cerebrovascular events within 3 months after TIA and assessed the incremental value of copeptin compared with the ABCD2 (age, blood, clinical features of TIA, duration of symptoms, presence of diabetes mellitus) and ABCD3-I (ABCD2, dual TIA [the presence of ≥2 TIA symptoms within 7 days], imaging [the presence of abnormal findings on neuroimaging]) scores.